About tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide
tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide (PubChem CID 158749839) has the molecular formula C74H68Cl3FN16O11
and a molecular weight of 1482.82 g/mol. Its IUPAC name is tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide.
Frequently Asked Questions
What is the IUPAC name of tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide?
The IUPAC name of tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide (CID 158749839) is tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide.
What is the SMILES notation for tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide?
The canonical SMILES for tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide is Cc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2nc1C.Cc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)O)c2nc1C.Cc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)OC(C)(C)C)c2nc1C.
What is the InChIKey of tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide?
The InChIKey is INIJOLPVJWZJTE-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H24ClFN6O3.C26H26ClN5O4.C22H18ClN5O4/c1-14-15(2)32-22-18-8-19(24(36)30-9-16-4-6-17(27)7-5-16)25(37)34(23(18)29-10-20(22)31-14)11-21(35)33-12-26(3,28)13-33;1-14-15(2)31-22-18-10-19(24(34)29-11-16-6-8-17(27)9-7-16)25(35)32(13-21(33)36-26(3,4)5)23(18)28-12-20(22)30-14;1-11-12(2)27-19-15-7-16(21(31)25-8-13-3-5-14(23)6-4-13)22(32)28(10-18(29)30)20(15)24-9-17(19)26-11/h4-8,10H,9,11-13H2,1-3H3,(H,30,36);6-10,12H,11,13H2,1-5H3,(H,29,34);3-7,9H,8,10H2,1-2H3,(H,25,31)(H,29,30).
What are the key properties of tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide?
tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide has a molecular weight of 1482.82 g/mol, XLogP of 9.62, 15 rotatable bonds, 4 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide is sourced from PubChem (CID 158749839), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).